Latest News
Conference Coverage
Hypertensive disease of pregnancy linked to earlier mortality
LAS VEGAS - Women who develop any form of hypertensive disease during pregnancy are at a higher risk of death, at least until age 50.
From the Journals
Sickle cell trait artificially lowers HbA1c
HbA1c levels systematically underestimate glucose levels in black patients who carry the sickle cell trait, researchers say.
Conference Coverage
Toddlers’ neurodevelopmental deficits linked with maternal diabetes
Children born to obese mothers with insulin-requiring type 2 diabetes showed neurodevelopmental deficits at age 2 years.
News
Our new year’s resolutions
Resolve to improve your use of electronic health records to make your life easier in the coming year.
Conference Coverage
Capping gestational weight gain didn’t deliver better pregnancy outcomes
Behavioral interventions moderated gestational weight gain, but reduced weight gain wasn’t linked to better pregnancy outcomes.
Feature
Travel ban affects international medical meetings
International medical conference leaders say the travel ban imposed by President Trump that blocks immigrants of seven Muslim countries from...
From the Journals
Unhealthy eating habits might precede depressive symptoms
Routinely skipping breakfast, eating 2 hours before bed, and engaging in other unhealthy eating behaviors may lead to depressive symptoms.
Feature
Trump nominates Neil Gorsuch as 9th Supreme Court justice
President Donald Trump has chosen Neil Gorsuch, a conservative judge who presides over Denver’s 10th Circuit, as his nominee for U.S. Supreme...
Conference Coverage
Even small weight loss can improve long-term atrial fib ablation success
ORLANDO – New data expand evidence that obesity reduces long-term success of ablation for atrial fibrillation.
Conference Coverage
Hypertension risk soars in offspring of early-HT parents
NEW ORLEANS – When assessing a patient’s future risk for hypertension, consider the age at which the parents developed the disease.
Conference Coverage
Semaglutide compares well with sitagliptin
NEW ORLEANS – Semaglutide, a GLP-1 agonist for type 2 diabetes that’s dosed weekly, was superior to daily sitagliptin in improving glycemic...